Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
1/19/18 AstraZeneca (AZN) Fasenra for Asthma Subscribers Only Subscribers Only Subscribers Only
1/19/18 TRACON (TCON) TRC105 for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) Subscribers Only Subscribers Only Subscribers Only
1/19/18 Otsuka (4768:JP) Rexulti for Schizophrenia Subscribers Only Subscribers Only Subscribers Only
1/19/18 Merck (MRK) Keytruda for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) Subscribers Only Subscribers Only Subscribers Only
1/18/18 PharmaMar (ZEL:SM) Zepsyre for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
01/20/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
01/20/18 Subscribers Only Subscribers Only Trial Data - Updated Results
01/20/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
01/20/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
01/20/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top